MAPT and Alzheimer disease: Specifically, the retina of AD patients exhibits neuronal and pericyte cell loss along with retinal manifestation of AD pathological hallmarks—amyloid β-protein (Aβ) plaques and hyperphosphorylated tau (p-Tau)9–13,16–27.